Patents by Inventor Bolanle AKINLADE

Bolanle AKINLADE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING ASTHMA IN PEDIATRIC SUBJECTS BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20220169739
    Abstract: Methods for treating or preventing asthma in a pediatric subject are provided. Methods comprising administering to a pediatric subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
    Type: Application
    Filed: October 4, 2021
    Publication date: June 2, 2022
    Inventors: Christine Xu, Bolanle Akinlade, Nikhil Amin, Marcella Ruddy
  • METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR
    Publication number: 20220110999
    Abstract: The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody. In certain embodiments, the methods of the present invention are used to treat severe AD in a patient whose disease is not controlled with systemic therapy (e.g., cyclosporine A) or when such therapy is inadvisable.
    Type: Application
    Filed: September 22, 2021
    Publication date: April 14, 2022
    Inventors: Allen RADIN, Neil GRAHAM, Bolanle AKINLADE, Gianluca PIROZZI, Xing SUN, Thomas HULTSCH, Brad S. SHUMEL, Ashish BANSAL
  • Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
    Patent number: 11167004
    Abstract: The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody. In certain embodiments, the methods of the present invention are used to treat severe AD in a patient whose disease is not controlled with systemic therapy (e.g., cyclosporine A) or when such therapy is inadvisable.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: November 9, 2021
    Assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology
    Inventors: Allen Radin, Neil Graham, Bolanle Akinlade, Gianluca Pirozzi, Xing Sun, Thomas Hultsch, Brad S. Shumel, Ashish Bansal
  • METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR
    Publication number: 20200246416
    Abstract: The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody. In certain embodiments, the methods of the present invention are used to treat severe AD in a patient whose disease is not controlled with systemic therapy (e.g., cyclosporine A) or when such therapy is inadvisable.
    Type: Application
    Filed: July 16, 2019
    Publication date: August 6, 2020
    Inventors: ALLEN Radin, NEIL GRAHAM, BOLANLE AKINLADE, GIANLUCA PIROZZI, XING SUN, THOMAS HULTSCH, BRAD S. SHUMEL, ASHISH BANSAL
  • Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
    Patent number: 10485844
    Abstract: The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody. In certain embodiments, the methods of the present invention are used to treat severe AD in a patient whose disease is not controlled with systemic therapy (e.g., cyclosporine A) or when such therapy is inadvisable.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: November 26, 2019
    Assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology
    Inventors: Allen Radin, Neil Graham, Bolanle Akinlade, Gianluca Pirozzi, Xing Sun, Thomas Hultsch, Brad S. Shumel, Ashish Bansal
  • Methods for Treating Severe Atopic Dermatitis by Administering an IL-4R Inhibitor
    Publication number: 20180078603
    Abstract: The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody. In certain embodiments, the methods of the present invention are used to treat severe AD in a patient whose disease is not controlled with systemic therapy (e.g., cyclosporine A) or when such therapy is inadvisable.
    Type: Application
    Filed: September 21, 2017
    Publication date: March 22, 2018
    Inventors: Allen RADIN, Neil GRAHAM, Bolanle AKINLADE, Gianluca PIROZZI, Xing SUN, Thomas HULTSCH, Brad S. SHUMEL, Ashish BANSAL